HbA1c screening in the community: Lessons for safety and quality management of a point of care programme

Health targets: More heart and diabetes checks. www.health.govt.nz/new-zealand-health-system/health-targets/about-health-targets/health-targets-more-heart-and-diabetes-checks. Health targets – 2013/14 quarter four – results summary. http://www.health.govt.nz/new-zealand-health-system/health-targets/how-my-dhb-performing/how-my-dhb-performing-2013-14/health-targets-2013-14-quarter-four-results-summary. Shephard, 2006, Cultural and clinical effectiveness of the ‘QAAMS’ point-of-care testing model for diabetes management in Australian aboriginal medical services, Clin. Biochem. Rev., 27, 161 Wells, 2017, The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: a cluster randomised controlled trial and qualitative investigation, PLoS One, 12, 10.1371/journal.pone.0174504 World Health Organization, 2011 Braatvedt, 2012, Understanding the new HbA1c units for the diagnosis of type 2 diabetes, N. Z. Med. J., 125 Sacks, 2011, Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus, Clin. Chem., 57, e1, 10.1373/clinchem.2010.161596 Roche Diagnostics Cobas b 101 Performance evaluation report. www.cobas.com/content/dam/cobas_com/pdf/product/cobas-b-101-system/cobas%20b%20101%20performance%20evaluation%20study%20report_8pg.pdf. Cox, 1985, Accuracy of perceiving blood glucose in IDDM, Diabetes Care, 8, 529, 10.2337/diacare.8.6.529 Jiang, 2014, Assessment of the performance of A1CNow(+) and development of an error grid analysis graph for comparative hemoglobin A1c measurements, Diabetes Technol. Ther., 16, 363, 10.1089/dia.2013.0289 Woodworth, 2014, Utilization of assay performance characteristics to estimate hemoglobin A1c result reliability, Clin. Chem., 60, 1073, 10.1373/clinchem.2013.220772 Cowley, 2013, Evaluation of the Roche Cobas B 101 instrument Lenters-Westra, 2010, Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria, Clin. Chem., 56, 44, 10.1373/clinchem.2009.130641 Lenters-Westra, 2014, Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria, Clin. Chem., 60, 1062, 10.1373/clinchem.2014.224311 Musaad, 2013, Point-of-care testing governance in New Zealand: a national framework, N. Z. Med. J., 126, 72 Herd, 2015, Clinical goverance and point of care testing at health provider level, N. Z. Med. J., 128, 41 New Zealand Point-of-Care Testing Advisory Group, 2014